HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Givenchy Miroir Cosmetics Collection Rounded Out With "Prism" Powders

This article was originally published in The Rose Sheet

Executive Summary

Givenchy will complete its prestige Miroir Colour Cosmetics Collection this fall with the introduction of Prismes Miroir Powders - the first face powders to be marketed under the recently revamped, couture-inspired makeup line.

You may also be interested in...



Givenchy Aims For Triple Crown With Kors, Jacobs, Kenzo Fragrances

Parfums Givenchy hopes to see its designer women's fragrances Michael by Michael Kors, Marc Jacobs and Flower by Kenzo rank in the top three within their limited U.S. distribution once the trio is on counter this fall, President and CEO Camille McDonald said.

Givenchy Miroir Cosmetics Extensions Debut Under Artistic Director Degennes

Givenchy Artistic Director Nicolas Degennes is tapping into his "high-art" makeup artist experience to extend Miroir lip and nail products into a full collection of color cosmetics. The "playful yet prestige" line will roll out this fall.

Givenchy Reworked Beaute Line To Reflect Couture Designer McQueen Era

Parfums Givenchy's beaute collection will undergo a complete overhaul to reflect the era of new Givenchy couture designer Alexander McQueen. The line's "evolution" will help separate it from the fashion house's founder Hubert de Givenchy and most recently, couture icon John Galliano.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS009533

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel